Readystate Asset Management LP Immunome Inc. Transaction History
Readystate Asset Management LP
- $3.27 Trillion
- Q2 2025
A detailed history of Readystate Asset Management LP transactions in Immunome Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 1,353,586 shares of IMNM stock, worth $13.4 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
1,353,586
Previous 224,240
503.63%
Holding current value
$13.4 Million
Previous $1.51 Billion
734.14%
% of portfolio
0.39%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
148Shares Held
66.5MCall Options Held
44.9KPut Options Held
4.24M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.28MShares$82 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.87MShares$48.3 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$46.4 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$44.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$40.4 Million3.27% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $120M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...